|
A mouse model of duodenal atresia
|
Project Leader Associate Professor Warrick Teague
|
|
|
A phase I/II double-blind, randomised controlled trial assessing effect of medicinal cannabis on overall quality of life for people with cancer
|
|
|
|
A5 SDHB Genomics Study
|
Head of Laboratory Dr Richard Tothill
|
|
|
Aboriginal and Torres Strait Islanders
|
Chair of Palliative Medicine Prof Jennifer Philip
|
|
|
ACRF Translational Research Laboratory
|
Group Leader Professor David S Ritchie
|
|
|
Advanced Limb Reconstruction
|
Head of Department of Surgery,
St. Vincent's Hospital,
Professor Peter Choong
|
|
|
Brain Cancer Invasion Group
|
Dr Stanley Stylli
|
|
|
Brain Cancer Microenvironment and Biology Laboratory
|
Dr Theo Mantamadiotis
|
|
|
Brain Tumours and Epilepsy
|
Associate Professor Andrew Morokoff
|
|
|
Breast Cancer
|
Head of Group Professor Bruce Mann
Lead Researcher Dr Anita Skandarajah
|
|
|
Buchanan laboratory: Oncogenomics (colorectal cancer)
|
Head of Laboratory Associate Professor Daniel Buchanan
|
|
|
CANARY (CANcer risk in patients with unexpected weight loss in primaRY care) Studies: Clinical Decision Support Systems for Cancer Prevention and Early Cancer Detection in Primary Care
|
Chief Investigator Dr. Javiera Martinez Gutierrez,
|
|
|
Coin Laboratory: Cancer Bioinformatics
|
Head of Laboratory Professor Lachlan Coin
|
|
|
Cancer Biology Research Group
|
Professor Graham Baldwin
|
|
|
Cancer Immunotherapy symptoms: the experience and expectations around management
|
Program Trial Coordinator Leeanne Pasanen
|
|
|
Cancer Signaling Research Laboratory
|
Dr Hong-Jian Zhu
|
|
|
Centre for research excellence in cervical cancer control
|
|
|
|
Characterisation of complex structural variation in bacterial and human genomes
|
Group Lead, Cancer Bioinformatics Professor Lachlan Coin
|
|
|
Circulating Biomarkers in Liver Malignancy
|
Professor Christopher Christophi
|
|
|
Clinical Trials
|
|
|
|
Completed Projects
|
|
|
|
Cost of Caregiving Study
|
|
|
|
Developing clinical genomic methods for cancer of unknown primary
|
Head of Laboratory Dr Richard Tothill
|
|
|
Elizabeth Vincan
|
Professor Elizabeth Vincan
|
|
|
The Psychosocial Health and Wellbeing Research (emPoWeR) Unit
|
Research Group Leader A/Prof Michelle Peate
|
|
|
Endocrine Surgery
|
Associate Professor Julie Miller
|
|
|
Enhance: A multi-centre, randomised phase IV study
|
|
|
|
Establishing patterns of primary health care usage in cancer at the end of life
|
Matthew Grant
|
|
|
Evaluating molecular biomarkers of anal cancer risk
|
|
|
|
Fertility After Cancer Predictor (FoRECAsT) Study
|
Project Lead A/Prof Michelle Peate
|
|
|
Fertility preservation in children and teenagers with cancer
|
Senior Lecturer Dr Yasmin Jayasinghe
|
|
|
Fertility Preservation Taskforce
|
A/Prof Yasmin Jayasinghe
|
|
|
Future Health Today: A randomised control trial of pharmacological therapies to reduce cardiovascular risk in people with chronic kidney disease and investigation of people at increased risk of cancer
|
Study Coordinator Ms. Sophia Chima,
|
|
|
Genomic tools for diagnosis of the presence of a solid tumour and for prediction of tumour subtype and likely treatment response from circulating tumour DNA
|
Group Lead, Cancer Bioinformatics Professor Lachlan Coin
|
|
|
Genomic tools for rapid diagnosis of bacterial infection using host and bacterial biomarkers
|
Group Lead, Cancer Bioinformatics Professor Lachlan Coin
|
|
|
Glioblastoma Survival Signaling Lab
|
Dr Rodney Luwor
|
|
|
Gynaecology Research Centre - Hickey Group
|
Research Group Leader Professor Martha Hickey
|
|
|
Head and Neck Tumour Stream Research Group
|
Professor David Wiesenfeld
|
|
|
Hollande laboratory: Tumour Heterogeneity in Metastatic Cancer
|
Head of Laboratory Professor Fred Hollande
|
|
|
Honorary Appointments’ Research Projects
|
|
|
|
Host responses to therapy and the tumour microenvironment contribute to the development of tumour resistance
|
Professor Christopher Christophi
|
|
|
How many women experience long-term side-effects after cancer and cancer treatment?
|
Project Lead A/Prof Michelle Peate
|
|
|
Human Liver Organoids
|
Project Lead Professor Kumar Visvanathan
|
St Vincent's Hospital
|
|
IC3 Trial: A Randomised Control Trial aiming to improve early diagnosis of liver cancer and improving patient health outcomes
|
IC3 National Manager Dr. Deborah De Guingand,
|
|
|
Identifying and characterising Lynch syndrome within the population
|
Head of Laboratory Dr Daniel Buchanan
|
|
|
Identifying biomarkers of risk and poor prognosis in CRC
|
Head of Laboratory Dr Daniel Buchanan
|
|
|
Identifying novel genetic risk factors for colorectal cancer
|
Head of Laboratory Dr Daniel Buchanan
|
|
|
Improving reproductive health through infectious diseases research
|
|
|
|
Improving the management of menopause symptoms in cancer survivorship
|
Project Lead A/Prof Michelle Peate
|
|
|
Informal Communities in Cancer Treatment
|
Project Lead Dr Matt Grant
|
|
|
Integrative genomics and immunobiology in Hairy Cell Leukaemia
|
Professor David S Ritchie
|
|
|
Inter and Intra-tumour heterogeneity in metastatic colorectal cancer
|
Group Leader, acting Head of Department Associate Professor Fred Hollande
|
|
|
Liver Group
|
Professor Christopher Christophi
|
|
|
Low Literacy Decision Aid about Reproductive Choices for Younger Women with Breast Cancer
|
Project Lead A/Prof Michelle Peate
|
|
|
MAGPIE Study: A genomic test intervention designed to provide patients with personalised melanoma, bowel, breast, and prostate cancer screening information
|
Study Coordinator Dr. Sibel Saya,
|
|
|
Manipulating Recipient Immunological Microenvironment to Improve Outcomes in Allogeneic Transplantation
|
Project Lead Dr Rachel Koldej
|
|
|
Manometric studies on oesophageal atresia and colorectal disorders
|
Project Leader Dr Sebastian King
|
|
|
Molecular Mechanisms of Tumour Resistance Laboratory
|
Dr Rodney Luwor
|
|
|
Molecular Microbiology and Reproductive Health Research Group
|
Honorary, Obstetrics and Gynaecology Royal Women's Hospital/Mercy Professor Suzanne M. Garland
|
|
|
National Pancreatic Cancer Roadmap Early Implementation Priorities
|
|
|
|
Neurosurgery
|
Professor Kate Drummond
|
|
|
Novel investigations and treatments for intractable, chronic constipation
|
Project Leader Dr Bridget Southwell
|
|
|
Novel treatments for colorectal disorders
|
Project Leader Dr Sebastian King
|
|
|
Opioid Pharmacogenomics
|
Palliative Medicine Physician and Medical Oncologist Dr Aaron K Wong
|
|
|
Optimising the management of patients awaiting liver transplantation
|
Professor Christopher Christophi
Senior Lecturer Michael Fink
|
|
|
PaCCSC RAPID Series - Cancer-related Lymphoedema
|
Beth Russell
|
|
|
Paediatric Fertility Decision Aid Study
|
Project Lead A/Prof Michelle Peate
|
|
|
Jennifer Philip
|
Group Leader Professor Jennifer Philip
|
|
|
Postnatal germ cells are controlled by FSH during ‘minipuberty’ at 3-6 months of age, and deranged by cryptorchidism to cause seminoma and infertility
|
Project Leader Dr Ruili Li
|
|
|
PRESIDE Trial: A Randomised Controlled Trial providing antidepressant medication information to patients with mild-to-severe depressive symptoms.
|
Trial Coordinator Dr Sibel Saya,
|
|
|
Priorities and Needs of Women Living with Advanced Cancer
|
Project Lead Dr Michelle Peate
|
|
|
Probiotic therapy
|
|
|
|
Promoting and advancing midlife health in women
|
Project Leader Professor Martha Hickey
|
|
|
Prostate Cancer
|
Head of Group Professor Christopher Hovens
Deputy Laboratory Head Associate Professor Niall Corcoran
|
|
|
Prostate Cancer Research Group
|
Professor Christopher Hovens
|
|
|
RAPID Postmarketing Study - Medicinal Cannabis
|
|
|
|
Recipient immunity as a determinant of long term outcome in bone marrow transplantation
|
Group Leader Professor David Ritchie
|
|
|
Regulation of cancer stem cell self-renewal in colorectal cancer
|
Group Leader, Acting deputy Head of Department Associate Professor Fred Hollande
|
|
|
Regulation of invadopodium function and involvement in cancer cell invasion
|
Dr Stanley Stylli
|
|
|
Renal supportive care of patients with advanced chronic kidney disease
|
Kathryn Ducharlet
|
|
|
Reproductive Steroids Research Group
|
Professor Mathis Grossmann, MD, PhD, FRACP
|
|
|
Revitalise Program
|
|
|
|
RoBiN (Risk of Breast Neoplasia): An acceptability and feasibility study of personalised screening
|
Lead Researcher Dr. Dulashi (Anna) Withanage Dona
|
|
|
The role of the essential biometal zinc in pathological and physiological processes
|
Professor Graham Baldwin
Dr Oneel Patel
Dr Joseph Ischia
|
|
|
Role of p-21-activated kinases in pancreactic cancer
|
Professor Graham Baldwin
Dr Mehrdad Nikfarjam
|
|
|
The role of the Renin Angiotensin System in tumour progression and recurrence following tumour resection
|
Professor Christopher Christophi
|
|
|
ROSELLA Study: Implementation of risk-stratified population screening for Australia’s most common cancers
|
Research Lead Dr. Sibel Saya,
|
|
|
SCRIPT Trial: A Randomised Controlled Trial utilising a genomic test as an intervention providing personalised bowel cancer screening information
|
Trial Coordinator Dr. Sibel Saya,
|
|
|
Serum biomarkers of brain cancer
|
Dr Andrew Morokoff
|
|
|
SMARTERScreen: A Randomised Controlled Trial based on evidence from SMARTScreen utilising SMS messages to prompt patients overdue with bowel cancer screening
|
|
|
|
Spinal Biology Laboratory
|
Doctor Gerald Quan
|
|
|
STEP Care Clinical Trial
|
Project Lead Anna Collins
|
|
|
Surgical Research Group
|
Chair of Paediatric Surgery Professor John M Hutson AO
|
|
|
Sushama Telwatte
|
Locarnini Fellow in Virology Dr. Sushama Telwatte
|
|
|
T cell function as a determinant of blinatumomab efficacy in B-ALL
|
Group Leader Professor David Ritchie
|
|
|
Targeting the angiogenic and osteoclastic pathways in spinal cancer
|
Doctor Gerald Quan
Doctor Gerald Quan
|
|
|
Targeting the Lymphatics in colorectal Liver metastasis
|
Professor Christopher Christophi
|
|
|
The assessment of oral cancer risk using a chair-side tool for salivary aldehyde production
|
Professor Michael McCullough
|
|
|
The Care Plus Study
|
|
|
|
The Care Plus Study
|
|
|
|
The CASSOWARY Trial: A Randomised Controlled Trial of the clinical utility and cost-effectiveness of a multi-cancer polygenic risk score in general practice
|
Research Fellow Dr. Sibel Saya,
|
|
|
The COMET Program
|
|
|
|
The IDEAL Care Trial: IDEntifying Advanced Liver Fibrosis in Primary Care
|
National Trial Coordinator Ms Eliza Smislja
|
|
|
The Partner Study
|
|
|
|
The role of invadopodia in glioma invasion and response to therapeutics
|
Dr Stanley Stylli
|
|
|
The role of miRNA in oral mucosal disorders
|
Professor Michael McCullough
|
|
|
Understanding how immune cell function is impacted by novel therapies in patients with B cell malignancies
|
Professor David S Ritchie
|
|
|
Understanding the aetiology of Serrated Polyposis Syndrome
|
Head of Laboratory Dr Daniel Buchanan
|
|
|
Understanding The Immune Environment in Metastatic Melanoma
|
Surgeon, Project Leader Dr David Gyorki
|
|
|
Undescended testis and inguinal hernia result from defects in the same mechanism
|
Project Leader Professor John M Hutson AO
|
|
|
Use of Connexin43 peptides as a treatment for glioma
|
Dr Stanley Stylli
|
|
|
Voices for Palliative Care
|
|
|
|
Western Health Cancer Research
|
Group Leader Dr Dishan Herath
|
|
|
Impact of risk-reducing bilateral salpingo-oophorectomy on non-cancer outcomes in young high-risk women: a multicentre prospective study.
|
Head, Department of Obstetrics and Gynaecology, The University of Melbourne, The Royal Women's Hospital Professor Martha Hickey
|
|